The estimated Net Worth of Bertil Lindmark is at least 820 千$ dollars as of 22 March 2022. Prof Lindmark owns over 14,604 units of Galecto stock worth over 217,844$ and over the last 4 years he sold GLTO stock worth over 0$. In addition, he makes 602,626$ as Chief Medical Officer at Galecto.
Sign up
Prof D GLTO stock SEC Form 4 insiders trading
Prof has made over 2 trades of the Galecto stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 14,604 units of GLTO stock worth 31,545$ on 22 March 2022.
The largest trade he's ever made was buying 14,604 units of Galecto stock on 22 March 2022 worth over 31,545$. On average, Prof trades about 3,321 units every 53 days since 2021. As of 22 March 2022 he still owns at least 16,604 units of Galecto stock.
You can see the complete history of Prof Lindmark stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Prof. Bertil Lindmark M.D., Ph.D. biography
Prof. Bertil Lindmark M.D., Ph.D. is the Chief Medical Officer at Galecto.
What is the salary of Prof D?
As the Chief Medical Officer of Galecto, the total compensation of Prof D at Galecto is 602,626$. There are 1 executives at Galecto getting paid more, with Dr. Hans T. Schambye having the highest compensation of 644,982$.
How old is Prof D?
Prof D is 66, he's been the Chief Medical Officer of Galecto since . There are no older and 4 younger executives at Galecto.
What's Prof D's mailing address?
Bertil's mailing address filed with the SEC is C/O GALECTO, INC., OLE MAALOES VEJ 3, COPENHAGEN N, G7, DK-2200.
Insiders trading at Galecto
Over the last 4 years, insiders at Galecto have traded over 2,298,261$ worth of Galecto stock and bought 1,911,769 units worth 28,139,830$ . The most active insiders traders include Holdings A/S Novo、Chau Quang Khuong、Carl Goldfischer. On average, Galecto executives and independent directors trade stock every 46 days with the average trade being worth of 2,037,418$. The most recent stock trade was executed by Advisors Llc Orbi Med Genes... on 15 August 2023, trading 822,680 units of GLTO stock currently worth 617,010$.
What does Galecto do?
Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a life-threatening progressive fibrotic disease of the lung; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is based in Boston, Massachusetts.
What does Galecto's logo look like?
Complete history of Prof Lindmark stock trades at Galecto
Galecto executives and stock owners
Galecto executives and other stock owners filed with the SEC include:
-
Dr. Hans T. Schambye,
Co-Founder, Pres, CEO & Director -
Prof. Bertil Lindmark M.D., Ph.D.,
Chief Medical Officer -
Anders Pedersen,
Chief Operating Officer -
Dr. Stephanie Oestreich Ph.D.,
Chief Bus. Officer -
Garrett Winslow,
Sr. VP & Gen. Counsel -
Jonathan P. Freve CPA, CPA,
Chief Financial Officer -
Prof. Tariq Sethi M.D., B.Sc., M.A., Ph.D., FRCP,
Co-Founder & Member of the Clinical Advisory Board - IPF -
Dr. Hakon Leffler,
Co-Founder -
Ulf J. Nilsson,
Co-Founder -
Advisors Llc Orbi Med Genes...,
-
Holdings A/S Novo,
10% owner -
Carl Goldfischer,
-
Anders Pedersen,
Chief Operating Officer -
Hans T. Schambye,
Chief Executive Officer -
Stephan Christgau,
Director -
Advisors Llc Orbi Med Advis...,
-
Bertil Lindmark,
Chief Medical Officer -
Jonathan Freve,
Chief Financial Officer -
Chau Quang Khuong,
Director -
Stephanie Oestreich,
Chief Business Officer -
Jayson Donald Alexander Dallas,
-
Amit Munshi,
-
Anne Prener,
-
David Shapiro,
-
Garrett Winslow,
General Counsel